Disease areas:
  • bones, joints and muscles
  • wounds and injuries
Last updated:
Author(s):
Joanna Lankester, Jin Li, Elias Levy Itshak Salfati, Marcia L Stefanick, Kei Hang Katie Chan, Simin Liu, Carolyn J Crandall, Shoa L Clarke, Themistocles L Assimes
Publish date:
21 November 2022
Journal:
International Journal of Epidemiology
PubMed ID:
36409989

Abstract

BACKGROUND: A later age at natural menopause (ANM) has been linked to several ageing-associated traits including an increased risk of breast and endometrial cancer and a decreased risk of lung cancer, osteoporosis and Alzheimer disease. However, ANM is also related to several proxies for overall health that may confound these associations.

METHODS: We investigated the causal association of ANM with these clinical outcomes using Mendelian randomization (MR). Participants and outcomes analysed were restricted to post-menopausal females. We conducted a one-sample MR analysis in both the Women’s Health Initiative and UK Biobank. We further analysed and integrated several additional data sets of post-menopausal women using a two-sample MR design. We used ≤55 genetic variants previously discovered to be associated with ANM as our instrumental variable.

RESULTS: A 5-year increase in ANM was causally associated with a decreased risk of osteoporosis [odds ratio (OR) = 0.80, 95% CI (0.70-0.92)] and fractures (OR = 0.76, 95% CI, 0.62-0.94) as well as an increased risk of lung cancer (OR = 1.35, 95% CI, 1.06-1.71). Other associations including atherosclerosis-related outcomes were null.

CONCLUSIONS: Our study confirms that the decline in bone density with menopause causally translates into fractures and osteoporosis. Additionally, this is the first causal epidemiological analysis to our knowledge to find an increased risk of lung cancer with increasing ANM. This finding is consistent with molecular and epidemiological studies suggesting oestrogen-dependent growth of lung tumours.

Related projects

The overall goal of this project is to study the causal roles of the 36 biomarkers currently being assayed in UK Biobank for development of…

Institution:
Stanford University, United States of America

All projects